Global Prostate Cancer Devices Market to grow at a CAGR of 13.48% over the period 2014-2019, Finds New Report

Report forecast the global prostate cancer devices market to grow at a CAGR of 13.48% over the period 2014-2019.

Prostate cancer is one of the most common cancer in men. It occurs in the prostate gland, a small walnut-shaped gland. The primary function of the prostate gland is to produce seminal fluid that nourishes and transports sperm. The occurrence of prostate cancer is age dependent and typically occurs in men aged 65 years and more. This disease exhibits no early symptoms, and most prostate cancers are slow growing. Prostate cancer treatment includes chemotherapy, surgery, cryotherapy, and hormonal/radiation therapy.

This report covers the present scenario and the growth prospects of the global prostate cancer devices market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of prostate cancer devices based on their applications.

Types of applications:

• External beam radiation therapy
• Radical prostatectomy
• Brachytherapy
• Cryotherapy
• HIFU

The report includes revenue generated from the following regions: Americas, APAC, and EMEA. It presents the vendor landscape and a corresponding detailed analysis of the top six vendors in the market. The vendor landscape in this report focuses on those vendors that provide access to new prostate cancer devices. 

Global Prostate Cancer Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

• Americas
• APAC
• EMEA

According to the report, an increase in the aging population is the primary contributor to the growth of the market. It is projected that nearly 2 billion people will be aged 60 years and above by 2050. With aging, a person becomes more susceptible to several age-related disorders including urological disorders such as prostate cancer in men.

Key players in the Global Prostate Cancer Devices Market: C. R. Bard, Elekta AB, Intuitive Surgical Inc., Siemens Healthcare, Theragenics Corp. and Varian Medical Systems

Other Prominent Vendors in the market are: Eckert & Ziegler BEBIG, EDAP TMS, Galil Medical, IsoRay, Philips Healthcare, Profound Medical and SonaCare Medical.

Market Driver

• Increase in Aging Population
• For a full, detailed list, view our report

Market Challenge

• Complications of Prostate Cancer Surgeries
• For a full, detailed list, view our report

Market Trend

• Adoption of Robotic Prostatectomy
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 91 pages, “Global Prostate Cancer Devices Market 2015-2019” report covers Executive Summary, List of Abbreviations, Scope of the Report, Market Research Methodology, Introduction, Market Landscape, Overview: Prostate Cancer, Market Segmentation by Type of Application, Geographical Segmentation, Buying Criteria, Market Growth Drivers, Drivers and their Impact, Market Challenges, Impact of Drivers and Challenges, Market Trends, Trends and their Impact, Vendor Landscape, Key Vendor Analysis.

For further information on this report, please visit- http://mrr.cm/4LZ

Find all Medical Devices Reports at: http://www.marketresearchreports.com/medical-devices

Global Post-traumatic Stress Disorder Therapeutics Market to grow at a CAGR of 1.09% over the period 2014-2019, Finds New Report

Report forecast the global PTSD therapeutics market to grow at a CAGR of 1.09% over the period 2014-2019.

PTSD is a psychological condition that develops after a person is exposed to any traumatic event, and it drains a person emotionally. According to the DSM-IV codes found in the Diagnostic and Statistical Manual of Mental Disorders, published by the American Psychiatric Association (APA), PTSD is classified under anxiety disorders. PTSD can occur in individuals of any age, irrespective of the gender; its symptoms can develop immediately after a traumatic event or during the course of time. Its symptoms normally include re-experience of the traumatic event, avoidance of the incidents, and abnormal mood swings. Treatments for PTSD include psychological counselling, which help in identifying the cause of the condition and providing counselling to come out of the situation. Medications present in the market help in reducing the symptoms during the course of the treatment.

This report covers the present scenario and the growth prospects of the global PTSD therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various generic, off-label, and branded therapies used for the treatment of PTSD. This report includes the segmentation of the market based on geography.

Key Regions

• Americas
• APAC
• EMEA       

According to the report, increased cases of accidents and violence boost market growth. The rise in conflicts between different countries has increased stress levels in individuals worldwide, particularly those in the military. Domestic and social violence also trigger the development of PTSD in people.

Key players in the Global PTSD Therapeutics Market: GlaxoSmithKline plc, Pfizer Inc. and Otsuka Pharmaceutical Co. Ltd.

Other Prominent Vendors in the market are: Abbott Laboratories, Addex Therapeutics, AstraZeneca, Azevan Pharmaceuticals, Baylor Research Institute, Cerecor, Chugai Pharmaceutical, Dart NeuroScience, Dr. Reddy's Laboratories, Edgemont Pharmaceuticals, Eli Lilly, F. Hoffmann-La Roche, Forest Laboratories, H. Lundbeck, Humanetics Pharmaceuticals, Intra-Cellular Therapies, Janssen Pharmaceuticals, Luye Pharma, Marinus Pharmaceuticals, Nanotherapeutics, Naurex, Neurocrine Biosciences, Novartis Pharmaceuticals, Suven, Synchroneuron, Takeda Pharmaceutical, Teva Pharmaceutical and Tonix Pharmaceuticals

Market Driver

• Growing Number of Accidents and Violence Worldwide
• For a full, detailed list, view our report

Market Challenge

• Unavailability of Standard Diagnostic Methods
• For a full, detailed list, view our report

Market Trend

• Rise in Public Awareness
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 71 pages, “Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019” report covers Executive Summary, List of Abbreviations, Scope of the Report, Market Research Methodology, Introduction, Market Landscape, Product Profiles, Introduction, PTSD Overview, Pipeline Analysis, Market Landscape, Market Segmentation by Class of Drug, Geographical Segmentation, Buying Criteria, Market Growth Drivers, Drivers and Their Impact, Market Challenges, Impact of Drivers and Challenges, Market Trends, Trends and Their Impact, Vendor Landscape, Global PTSD Therapeutics Market: Key Takeaways, Key Vendor Analysis.

For further information on this report, please visit- http://mrr.cm/4L4

Find all Treatments Reports at: http://www.marketresearchreports.com/treatments

Global Hearing Aids Market to grow at a CAGR of 4.68% during the period 2014-2019; Finds New Report

Report forecast the global hearing aids market to grow at a CAGR of 4.68% during the period 2014-2019.

Hearing aids are devices that amplify sound. Hearing aids cannot restore the normal functioning of the ear, only improve the perception of sound in people with hearing impairment. Untreated hearing loss causes embarrassment, social stress, tension, and fatigue. According to the American Speech-Language-Hearing Association, hearing loss is associated with conditions such as dementia. The majority of the people with hearing impairment can be treated with hearing aids.

Factors such as changing demographics and high prevalence of hearing loss are driving market growth. The market has witnessed immense technological advances. These factors, combined with demand in emerging countries, high adoption rates, and reimbursement schemes have resulted in the growth of the market.

The report covers the present scenario and the growth prospects of the global hearing aids market for the period 2015-2019.

According to the report, the prevalence of hearing loss among adults aged above 65 is considered to be five times higher than those aged below 65. As a person ages, the hair cells in the ear get damaged. This factor and other age-related disorders lead to hearing loss in most of the elderly individuals. The rising aged population with impaired hearing is driving the market globally.

Further, the report states that people with hearing impairment avoid using expensive hearing aids that have unknown levels of advantage, or the benefits provided are less than the product cost. These individuals prefer devices that offer hearing assistance to their daily lifestyle and are discreet in appearance.

Global Hearing Aids Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, EMEA, and the Americas; it also covers the global hearing aids market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the Global Hearing Aids Market: GN Store Nord A/S, Sonova Holding AG and William Demant Holdings AG (WDH)

Other Prominent Vendors in the market are: Amplifon, Amplisound, Audina, Cochlear, Elkon, Med-El, Rayovac MicroPower Batteries, Rion, SeboTek Hearing Systems, Siemens, Starkey, Sonovation and Widex

Key Geographies

• Americas
• APAC
• EMEA

Market Driver

• Changing Demographics
• For a full, detailed list, view our report

Market Challenge

• Need for Skilled Dispensers in Developing Countries
• For a full, detailed list, view our report

Market Trend

• Innovations in Technology
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 60 pages and 25 Exhibits “Global Hearing Aids Market 2015-2019” report covers Executive Summary, List of Abbreviations, Scope of the Report, Market Research Methodology, Introduction, Global Audiological Devices Market: An Overview, Market Landscape, Market Segmentation by Product, Geographical Segmentation, Buying Criteria, Market Growth Drivers, Drivers and Their Impact, Market Challenges, Impact of Drivers and Challenges, Market Trends, Trends and their Impact, Vendor Landscape, Key Vendor Analysis.

For further information on this report, please visit- http://mrr.cm/4u9

Find all Medical Devices Reports at: http://www.marketresearchreports.com/medical-devices

Global Forensic Technologies Market to grow at a CAGR of 8.34 % over the period 2014-2019; Finds New Report

Report forecast the global forensic technologies market to grow at a CAGR of 8.34 % over the period 2014-2019.

Forensic technology is an important part of criminal investigations and is used for the analysis, identification, and evaluation of physical evidence gathered from a crime scene. Law enforcement agencies and the legal sector are the major end-users of this technology as it is helpful for them to solve cases. The increased acceptance of technology, especially DNA testing technology, has contributed to the growth of the global forensics technologies market.        

This report covers the present scenario and the growth prospects of the global forensic technologies market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the application forensic technologies in the healthcare sector. In terms of application, the market is segmented into two: DNA fingerprinting technology and forensic analytical techniques.

According to the report, the increase in the use of DNA profiling is one of the major drivers in the market. As crime investigations have become more challenging, law enforcement agencies are looking for advanced technologies such as DNA profiling to increase the efficiency, potential, and value of forensics, thereby shortening the delivery time of results.

Further, the report states that the expensive nature of forensic technology limits market growth. The high cost prevents small departments from utilizing this technology, leading to underuse.

Global Forensic Technologies Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and APAC and EMEA; it also covers the global forensic technologies market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

key players in the Global Forensic Technologies Market: Agilent Technologies Inc., Eurofins, LGC Forensics, NMS Labs and Thermo Fisher Scientific Inc.

Other Prominent Vendors in the market are: ACR Data Recovery, BAE Systems, Bio-Rad Laboratories, Capsicum Group, Computer Forensics, Creative Forensic Services, Cyber Agents, Forensics Consulting Solutions, Forensic Pathways, Foster + Freeman, Global Digital Forensics, IntegenX, Leica Geosystems, MorphoTrust USA and Neogen Corp., Orchid Cellmark, PAPILLON ZAO and Tri-Tech Forensics

Key Regions

• Americas
• APAC
• EMEA

Market Driver

• Increased Use of DNA Profiling
• For a full, detailed list, view our report

Market Challenge

• Expensive Nature of Forensic Technology
• For a full, detailed list, view our report

Market Trend

• New Technological Capabilities
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 74 pages and 28 Exhibits “Global Forensic Technologies Market 2015-2019” report covers Executive Summary, List of Abbreviations, Scope of the Report, Market Research Methodology, Introduction, Overview of DNA Profiling, Market Landscape, Market Segmentation by Application, Geographical Segmentation, Buying Criteria, Market Growth Drivers, Drivers and their Impact, Market Challenges, Impact of Drivers and Challenges, Market Trends, Trends and their Impact, Vendor Landscape, Key Vendor Analysis.

For further information on this report, please visit- http://mrr.cm/4uV

Find all Biotechnology Reports at: http://www.marketresearchreports.com/biotechnology

Global Endoscopic Camera System Industry 2015 Market Report; Launched via MarketResearchReports.com

2015 Global Endoscopic Camera System Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Endoscopic Camera System industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

The report firstly introduced the Endoscopic Camera System basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Endoscopic Camera System industry; 3.) the North American Endoscopic Camera System industry; 4.) the European Endoscopic Camera System industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

Spanning over 164 pages, “Global Endoscopic Camera System Industry 2015 Market Research Report” report covers Endoscopic Camera System Industry Overview, Asia Endoscopic Camera System Industry, North American Endoscopic Camera System Industry, Europe Endoscopic Camera System Industry Analysis, Endoscopic Camera System Marketing Channels and Investment Feasibility, Global Endoscopic Camera System Industry Conclusions.

For further information on this report, please visit- http://mrr.cm/4u7

Production and Market of Chinese Dental Laser Industry 2015-2020 Proposal, New Report Launched

Dental laser is a new treatment for oral medicine, and it has about 6 kinds of laser had applied to medical treatment, e.g. CO₂, Nd: YAG, Diode, Er:YAG, Er, Cr: YSGG, and Nd: YAP. Compare to western countries, China is underdevelopment in dental laser equipment realm, and clinic application as well. Base on the research from AskCI, 1,500 dental lasers had produced in China in 2014, that market cap worth 300 million.

The third oral epidemiological study shows over 90% of Chinese population have oral diseases. People would have more needs on oral care and oral cosmetic surgery, as people have better disposable personal incomes. Consequently, the demand of dental laser is expanding; in addition, by the technology and government political supports, the dental laser market is extremely large and profitable in the foreseeable future.

THE AIM OF THIS REPORT

• To provide readers with comprehensive & in-depth understanding of Chinese dental laser industry;
• To introduce major players of dental laser industry;
• To disclose market size of Chinese dental laser industry;
• To analyze competitions of dental laser industry;
• To analyze demand and supply of Chinese dental laser industry;
• To analyze dental laser industry chain;
• To understand position of China’s dental laser trade in the world;
• To reveal operation situation of major players in dental laser industry.

2. SCOPE OF INVESTIGATION

The report will investigate Chinese dental laser industry from the following aspects:

• Domestic market size
• Business environment
• Supply and demand
• Import and export
• Forecast and prospective
• Industry chain
• Key players
• Strategy and tactic
• Investment risks and opportunity
• Etc.

Spanning over 200 pages, “Production and Market of Chinese Dental Laser Industry 2015-2020 Proposal” report covers Executive Summary, Definition and Methodology, Dental Laser Industry Macro-Environment, 2014, Demand/Supply of Chinese Dental Laser Market, Industry chain, Import/Export Statistics, 2009-2015, Chinese Bellwether Company, Prospective and Trends, 2015-2020, Dental Laser Business Strategy and Tactics.

For further information on this report, please visit- http://mrr.cm/46F

Find all Dental Reports at: http://www.marketresearchreports.com/dental

Market Analysis of Overseas Medical Services Agency Industry in China 2015-2020 Proposal, New Report Launched

According to Transparency Market Research, the market scale of global medical tourism market will grow from USD10 billion to USD30 billion by 2019. Medical organizations from countries such as US, Japan, South Korea, etc. have introduced businesses in China.  Take Massachusetts General Hospital as an example, it has taken 40 Chinese patients in 2012, which rose to about 100 in 2013. By 2014, there were over 100,000 patients waiting for overseas medical treatment in China.

By far, the demands for overseas medical services mainly focus on tumor treatment, cosmetology, high-end body check, etc. Due to high market potential, lots of services agencies have emerged in the market. It was estimated that by 2020, the market value of overseas medical services agency industry will reach RMB13 billion.

In this report, Publisher will further disclose market potential and commercial opportunities for overseas medical services agency industry in China. Recommendations will be given at the end of the report to describe the prospect and provide suggestions for strategy making.

1) The Aim of Report

• To provide readers with comprehensive and in-depth understanding of Chinese overseas medical services agency industry;
• To analyze the market and current development of the industry;
• To discover drivers and barriers of the industry;
• To reveal opportunities for overseas medical services agency industry in China. 

2) Benefit from the Report

• Obtain latest info of overseas medical services agency industry, such as market analysis, current development, key players, etc.;
• Discover market opportunities in different segments;
• Find out how Chinese overseas medical services agency market will change and how your business can be involved in;
• Keep informed of your competitors/their activities in the globe and in China;
• Learn about key market drivers and barriers;
• Share this information within your organization using free global intranet license.

2. SCOPE OF INVESTIGATION

The report will investigate Chinese overseas medical services agency industry from the following aspects:

• Market analysis;
• Current development;
• Key players;
• Future trend;
• Commercial opportunity.

Spanning over 200 pages, “Market Analysis of Overseas Medical Services Agency Industry in China 2015-2020 Proposal” report covers Executive Summary, Definition and Methodology, Overview of Overseas Medical Services Agency in China, Market Demand of Overseas Medical Services Agency Industry by Market Segment, Key Players in Overseas Medical Services Agency Industry, Prospect of Overseas Medical Services Agency Industry in China, Conclusion and Recommendations.

For further information on this report, please visit- http://mrr.cm/46t

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

Big Data in Healthcare 2015 - 2020, New Report Launched

The global healthcare industry faces three key challenges. First is the requirement for cost reduction without jeopardizing the quality and management of healthcare services for everyone. The second challenge involves the significant increase in healthcare concerns, ranging from rising rate of chronic diseases, aging population and the dynamic consumer demands, including accessibility and health care expectations. The third is the shifting paradigm in healthcare characterized by reactive healthcare system to proactive health care system.

Medical data represents a large, rapidly growing, and mostly unstructured data residing in multiple locations including lab and imaging systems, physician notes, medical correspondence, claims, CRM and financial systems. With resizing costs with the healthcare industry, there is an imperative to reduce the cost of care and efficiently manage resources without compromising patient care.  Healthcare organizations have the opportunity to leverage big data technology to perform analytics to improve care and profitability.

This research evaluates the healthcare landscape and the factors which are facilitating the need for incorporation of big data technologies and solutions.  This research also evaluates the need for a data-driven healthcare organization as a new paradigm to determine quality metrics, data source integration, and data security management.  The report assesses big data relative to organizational goals for achieving a comprehensive healthcare system.

The report also focuses on the opportunities to leverage big data in healthcare for improved healthcare operations in terms of cost reduction including fraud detection.  Publisher evaluates key players including Explorys, Humedica, InterSystems, Pervasive, Clinical Query, GNS Healthcare, OmedaRX, and Sogeti Healthcare.  All purchases of Publisher reports includes time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.

Target Audience:

• Data analytics companies
• Big Data application developers
• Telecommunications companies
• Big data management companies
• Healthcare institutions of all types
• Investors in Big Data infrastructure

Spanning over 46 pages, “Big Data in Healthcare 2015 - 2020” report covers Executive Summary, Introduction, Big Data in Healthcare, Impact of Trends, Big Data Health Care Solutions, Future Outlook, Conclusions.

For further information on this report, please visit- http://mrr.cm/46N

Find all Pharma and Healthcare Technology Report at:

http://www.marketresearchreports.com/pharma-healthcare-technology

Asthma Drugs Market in the US to grow at a CAGR of 4.64% over the period 2014-2019; Finds New Report

Report forecast the asthma drugs market in the US to grow at a CAGR of 4.64% over the period 2014-2019.

Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors. The American Academy of Allergy Asthma and Immunology classifies asthma under four categories: exercise-induced asthma, allergic asthma, occupational asthma, and childhood asthma. The Asthma and Allergy Foundation of America classifies asthma into two categories: allergic asthma and non-allergic asthma. It is an incurable disease but can be controlled with the help of diagnosis at the right time, followed by regular therapy.

This report covers the present scenario and the growth prospects of the asthma drugs market in the US for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sale of various classes of drugs used to treat asthma, which include:

• Bronchodilators
• Leukotriene antagonists
• Mast cell stabilizers
• Immunosuppressants
• Combination of LABA/ICS

According to the report, pharmaceutical companies are developing drugs that have a better safety and efficacy profile than those already available in the market. These drugs are undergoing clinical trials or are awaiting approval by regulatory agencies. For instance, NVA237 by Novartis and Mepolizumab by GlaxoSmithKline are among the most promising drugs for the treatment of asthma. Mepolizumab by GlaxoSmithKline was submitted for approval as a maintenance treatment for severe eosinophilic asthma to the US Food and Drug Administration (FDA) in November 2014. Tralokinumab by AstraZeneca is another promising molecule, which is under phase III clinical trials.

Further, the report states that the unknown etiology of the condition makes it difficult for pharmaceutical companies to develop a curative drug for the treatment of asthma.

Asthma Drugs Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the asthma drugs market in the US: AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline and Merck

Other Prominent Vendors in the market are: Abbott Laboratories, Addex Therapeutics, Alkermes, AstraZeneca, Aurobindo Pharma, Avanir Pharmaceuticals, Cerecor, Chugai Pharmaceutical, Dart NeuroScience, Dr. Reddy's Laboratories, Edgemont Pharmaceuticals, E-Therapeutics, Euthymics, Evotec, F. Hoffmann-La Roche, Fabre Kramer, Gedeon Richter, H. Lundbeck, Intra-Cellular Therapies, Janssen Pharmaceuticals, Lupin, Luye Pharma, MSI Methylation Sciences, Naurex, Neuralstem, Novartis, Opko Health, Otsuka Pharmaceutical, Pierre Fabre, Shire, SK Biopharmaceuticals, Somerset Pharmaceuticals, Sun Pharmaceutical, Sunovion Pharmaceuticals, Suven, Takeda Pharmaceutical, Teva Pharmaceutical, Torrent Pharmaceuticals and Valeant Pharmaceuticals

Market driver

• Rise in disease prevalence
• For a full, detailed list, view our report

Market challenge

• Unknown disease etiology
• For a full, detailed list, view our report

Market trend

• Popularity of combination therapies
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 103 pages and 49 Exhibits “Asthma Drugs Market in the US 2015-2019” report covers Executive Summary, List of Abbreviations, Scope of the Report, Market Research Methodology, Introduction, Disease Overview, Pipeline Portfolio, Market Landscape, Market Segmentation by Class of Drug, Bronchodilators, Combination of LABA/ICS, Immunosuppressants, Leukotriene Antagonists, Mast Cell Stabilizers, Buying Criteria, Market Growth Drivers, Drivers and their Impact, Market Challenges, Impact of Drivers and Challenges, Market Trends, Trends and Their Impact, Vendor Landscape, Key Vendor Analysis.

For further information on this report, please visit- http://mrr.cm/42V

Find all Drug Delivery Reports at: http://www.marketresearchreports.com/drug-delivery

Global Sports Medicine Physician Survey - 2014, New Report Launched

Global Physician Surveys are conducted by highly trained moderators with years of experience in applying Publisher’s rigorous methodology to ensure balanced responses and to elicit keen insight from physicians, surgeons, specialists and other medical professionals. iData’s Global Physician Surveys are used to garner brand awareness, product preferences, message feedback and positioning.

Physician Surveys allow the inclusion of a diverse range of medical professionals in broader geographical areas. They also eliminate group bias and allow for interactive one-on-one feedback as well as flexibility to expose the respondent to interactive or static media.

The Global Sports Medicine Physician Survey report is a global survey regarding end-user attitudes and perceptions towards Hyaluronic Acid Viscosupplementation (HAV), Concentrated Bone Marrow Aspirate (cBMA) and Platelet-Rich Plasma (PRP) products. Responses from over 200 orthopedic surgeons from the United States and several other countries were gathered in person at the annual meeting of the American Academy of Orthopedic Surgeons.

For further information on this report, please visit- http://mrr.cm/42D

Find all Healthcare Report at: http://www.marketresearchreports.com/healthcare

US Market For Dental Bone Graft Substitutes, Barrier Membranes and Other Biomaterials - 2011-2021, New Report Launched

In the majority of cases, tooth loss is caused by periodontal disease and not tooth decay or caries. If not treated early, periodontal disease can become severe enough to not only permanently damage natural teeth, but also cause bone and hard tissue loss. Bone loss can also be caused by tooth extractions, accidents, chemicals and aging. Until the advent of bone graft materials, bone loss was considered permanent. The loss of bone can cause discomfort and prevent patients from receiving dental implants.

Bone grafting procedures using bone graft substitutes (BGSs) are performed to repair bone loss. Bone grafting can be performed during periodontal procedures in an attempt to save a tooth, or during a dental implant procedure to replace a tooth. Tissue engineering products and dental membranes can be used in conjunction with BGSs to increase the rate and extent of bone regeneration.

Dental bone graft substitutes are used for packing the space left by missing bone and for stimulating the growth of new bone. In addition to these functions, the use of BGS has proven to be an efficient way to enhance bonding, healing and longevity in traditional dental implants.

The volume of BGS used in a bone grafting procedure depends on the location and size of the bone that needs repair. In general, far less bone graft material is used in a dental procedure compared to an orthopedic bone grafting procedure..

The overall dental bone graft substitute and other biomaterials market is expected to show growth a few percentage points higher than the dental implant market. This correlates with the increased number of dental implant procedures that incorporate some sort of bone regenerative product, be it a growth factor, or a bone graft substitute coupled with a barrier membrane.

Spanning over 174 pages, “US MARKET FOR DENTAL BONE GRAFT SUBSTITUTES, BARRIER MEMBRANES AND OTHER BIOMATERIALS - 2011-2021” report covers Executive Summary, Research Methodology, U.S. Dental Bone Graft Substitute And Other Biomaterials Market Overview, Procedure Numbers, Dental Bone Graft Substitute Market, Dental Growth Factor Market, Dental Barrier Membrane Market. The report covered companies are - Geistlich, Zimmer Dental, ACE Surgical, BioHorizons, LifeNet Health, Osteogenics, DENTSPLY Implants, BIOMET 3i, Medtronic, AB Dental, Dentaurum, Dentium, Dyna Dental, Exactech, Impladent, Implant Direct.

For further information on this report, please visit- http://mrr.cm/42R

Find all Dental Report at: http://www.marketresearchreports.com/dental

US Interventional Cardiology Device Market - 2011-2021, New Report Launched

Interventional cardiology is a minimally-invasive technique that uses catheters to treat coronary arterial disease, which is one of the leading causes of death in the United States. The most common interventional cardiology procedure is percutaneous transluminal coronary angioplasty (PTCA), which is performed for the management of coronary atherosclerosis.

There are many different types of complementary devices used during interventional cardiology procedures. These devices include coronary stents, PTCA and cutting balloon catheters, balloon-inflation devices, interventional coronary catheters and guidewires, coronary embolic protection devices, coronary atherectomy devices, coronary thrombectomy devices, coronary chronic total occlusion devices, coronary introducer sheaths, coronary vascular closure devices, diagnostic coronary catheters and guidewires, fractional flow reserve (FFR) guidewires, intravascular ultrasound (IVUS) catheters and optical coherence tomography (OCT) catheters.

The interventional cardiology market has been declining recently due to decreases in stenting procedures. In recent years, over-stenting has been scrutinized heavily, with multiple studies estimating that approximately 30% of stenting is unnecessary. This scrutiny has resulted in a significant decrease in the stent market, and since this market is by far the largest out of the total interventional cardiology market, these declines have had a significant negative impact on the total market.

Many established standard items have become commodities and are close to homogeneous in their substitutability. Thus, it has been and will continue to be the role of new or specialized devices that receive positive clinical trials to act as catalysts for growth and to increase the market share of companies that are able to capitalize on the opportunity.

Spanning over 260 pages, “US INTERVENTIONAL CARDIOLOGY DEVICE MARKET - 2011-2021” report covers Executive Summary, Research Methodology, Procedure Numbers, Bare-Metal And Drug-Eluting Stent Market, Ptca And Cutting Balloon Market, Balloon-Inflation Device Market, Interventional Coronary Catheter Market, Interventional Coronary Guidewire Market, Coronary Embolic Protection Device Market, Coronary Atherectomy Device Market, Coronary Thrombectomy Device Market, Coronary Chronic Total Occlusion Crosser Market, Introducer Sheath Market, Coronary Vascular Closure Device Market, Diagnostic Coronary Catheter And Guidewire Market, Intravascular Ultrasound Catheter Market, Optical Coherence Tomography Catheter Market. The report covered companies are - Angio Dynamics, Spectranetics, Argon Medical, Volcano Therapeutics, AccessClosure, Merit Medical Systems, B. Braun, C. R. Bard, Marine Polymer Technologies, Smiths Medical, Teleflex Medical, AngioScore FlowCardia, Asahi Intecc Medical.

For further information on this report, please visit- http://mrr.cm/426

Find all Medical Devices Report at: http://www.marketresearchreports.com/medical-devices

Europe Interventional Cardiology Device Market (15 Countries) - 2011-2021, New Report Launched

Coronary arterial disease is one of the leading causes of death in Europe. Interventional cardiology is a minimally invasive technique that uses catheters to treat coronary arterial disease. The most common interventional cardiology procedure is percutaneous transluminal coronary angioplasty (PTCA), which is performed for the management of coronary atherosclerosis. There many different types of complementary devices used during interventional cardiology procedures. These devices include:

• Coronary stents,
• PTCA balloon catheters,
• Interventional coronary catheters and guidewires,
• Coronary embolic protection devices,
• Coronary atherectomy devices,
• Coronary introducer sheaths,
• Coronary vascular closure devices,
• Diagnostic coronary catheters and guidewires,
• Fractional flow reserve (FFR) guidewires,
• Intravascular ultrasound (IVUS) catheters,
• Optical coherence tomography (OCT) catheters.

Cardiovascular disease (CVD) is a common illness, afflicting one in every three individuals in Europe. The effects of CVD can vary from simple high-blood pressure to a fatal stroke. Interventional cardiology is primarily applied to the treatment of coronary heart disease (CHD), which is a specific cardiovascular illness. CHD encompasses myocardial infarction (MI) and angina pectoris, diseases that account for over half of all CVD cases.

The interventional cardiology market includes coronary stents, percutaneous transluminal coronary angioplasty (PTCA) balloon catheters, interventional catheters and guidewires, diagnostic catheters and guidewires, coronary introducer sheaths, embolic protection devices, atherectomy devices, drug-eluting stents and balloons, chronic total occlusion (CTO) devices, vascular closure devices (VCDs), intravascular ultrasound (IVUS) catheters and optical coherence tomography (OCT) catheters.

Advancements in specific technologies and practices such as drug management, drug-eluting stents, drug-eluting balloons, specialty guidewires, bioabsorbable stents, fractional flow reserve guidewires and various imaging modalities will account for a great deal of the growth in the total market for interventional cardiology devices. Many of the established standard products have essentially become commodities and are close to homogeneous in their substitutability. Thus, the responsibility is placed upon new or specialized devices that receive positive clinical trials to act as catalysts for growth and to increase the market share of companies that are able to capitalize on such opportunities. For established items such as catheters, guidewires and introducers, companies will have the opportunity to utilize distribution networks and the bundling of multiple products in order to increase revenues as seen with the larger European markets.

Spanning over 386 pages, “Europe Interventional Cardiology Device Market (15 Countries) - 2011-2021” report covers Executive Summary, Research Methodology, Europe Interventional Cardiology Device Market Overview, Country Profiles, Angioplasty And Angiography Procedure Numbers, Coronary Stent Market, Percutaneous Transluminal Coronary Angioplasty Balloon Catheter Market, Interventional Coronary Catheter Market, Interventional Coronary Guidewire Market, Coronary Introducer Sheath Market, Coronary Embolic Protection Device Market, Coronary Atherectomy Device Market, Diagnostic Coronary Catheter And Guidewire Market, Fractional Flow Reserve Guidewire Market, Coronary Vascular Closure Device Market, Intravascular Ultrasound Catheter Market, Optical Coherence Tomography Catheter Market. The report covered companies are - Abbott Laboratories, Cordis, St. Jude Medical, Terumo, Medtronic, Volcano Therapeutics, Biotronik, Biosensors, Hexacath, Boston Scientific, B. Braun, Spectranetics.

For further information on this report, please visit- http://mrr.cm/42E

Find all Medical Devices Report at: http://www.marketresearchreports.com/medical-devices